Sign in

Elizabeth Anderson

Senior Managing Director and Healthcare Services Equity Research Analyst at Evercore

Elizabeth Anderson is a Senior Managing Director and Healthcare Services Equity Research Analyst at Evercore ISI, specializing in the medical and healthcare services sector. She covers a wide range of medical and retail/wholesale companies including major names like CVS Health, Rite Aid, Omada Health, Syneos Health, and Oak Street Health, and has delivered notable calls such as a 145.3% return on Thorne Healthtech. Anderson maintains a performance record with a 40% success rate and an average return of -6.5% per rating, with the majority of recommendations being buys. She has issued over 492 stock ratings during her tenure and holds CFA qualification; her coverage primarily spans US-listed NYSE and NASDAQ medical companies since joining Evercore ISI, and she is recognized for evidence-based sector research and tactical outperform recommendations.

Elizabeth Anderson's questions to CARDINAL HEALTH (CAH) leadership

Question · Q1 2026

Elizabeth Anderson inquired whether the guidance includes the impact of Rite Aid volume shifting due to CVS closing, and sought clarification on potential opportunities arising from policy and regulatory changes in Washington D.C. given Cardinal Health's diverse business mix.

Answer

CEO Jason Hollar indicated that while Cardinal Health likely picked up a portion of the Rite Aid volume, it's not the primary driver of the broad-based strength. Regarding policy changes, he stated that Cardinal Health aligns with the administration's goal of affordable, innovative healthcare, suggesting such changes could be neutral to positive by driving utilization, though the exact impact on utilization and pricing remains hard to define.

Ask follow-up questions

Question · Q1 2026

Elizabeth Anderson inquired if the updated guidance includes the impact of Rite Aid volume shifting due to the CVS closing, and sought clarification on potential opportunities or impacts from policy and regulatory changes in Washington D.C. given Cardinal Health's diverse business mix.

Answer

CEO Jason Hollar explained that while Cardinal Health is likely picking up a greater share of Rite Aid's volume, it's not the primary driver of overall strength. Regarding policy changes, he stated the company aligns with the administration's goal of affordable, innovative healthcare, viewing such changes as neutral to positive for utilization and patient needs, with no material change to the solid utilization environment expected.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts